This guideline covers increasing immunisation uptake among children and young people aged under 19 years in groups and settings where immunisation coverage is low. It aims to improve access to immunisation services and increase timely immunisation of children and young people. It also aims to ensure babies born to mothers infected with hepatitis B are immunised.
In September 2017, we added links to the online version of the Green Book, parts of recommendation 6 were removed to bring it in line with the incorporation of hepatitis B vaccination into the standard routine vaccinations for babies, and terminology throughout was updated to reflect current public sector structures for commissioning and delivery of immunisation services.
This guideline includes recommendations on:
- immunisation programmes
- information systems for recording immunisation status
- training for staff involved in immunisation services
- contribution of nurseries, schools and further education colleges
- targeting groups at risk of not being fully immunised
- hepatitis B immunisation for infants
Who is it for?
- Healthcare professionals
- Commissioners and providers
- People who work in children’s services and local authorities
- People who work in schools, colleges and workplaces
- People who work in the private, voluntary and community sectors
- Parents, carers and young people
Is this guideline up to date?
We checked this guideline in August 2017. We found no new evidence that affects the recommendations in this guideline.
Guideline development process
This guideline was previously called reducing difference in the uptake of immunisations.
The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, professionals and practitioners are expected to take this guideline fully into account, alongside the individual needs, preferences and values of their patients or the people using their service. It is not mandatory to apply the recommendations, and the guideline does not override the responsibility to make decisions appropriate to the circumstances of the individual, in consultation with them and their families and carers or guardian.
All problems (adverse events) related to a medicine or medical device used for treatment or in a procedure should be reported to the Medicines and Healthcare products Regulatory Agency using the Yellow Card Scheme.
Local commissioners and providers of healthcare have a responsibility to enable the guideline to be applied when individual professionals and people using services wish to use it. They should do so in the context of local and national priorities for funding and developing services, and in light of their duties to have due regard to the need to eliminate unlawful discrimination, to advance equality of opportunity and to reduce health inequalities. Nothing in this guideline should be interpreted in a way that would be inconsistent with complying with those duties.
Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible.